Meet the Leadership Team
Nathan Bahary, MD, Ph.D., a medical oncologist, was most recently the Medical Director of the Pancreatic Cancer Program, Co-Director of the UPMC Pancreatic Cancer Center of Excellence and Co-Director of the UPMC Phase II program. He is known for his research and clinical activities in the field of gastrointestinal cancers in general, and particularly in pancreatic cancer.
Dr. Bahary earned his MD degree at the Cornell University School of Medicine and his PhD in genetics at Rockefeller University. He served a clinical fellowship at Harvard Medical School, was an intern and resident at Beth Israel Hospital, and did postdoctoral work at Dana-Farber Cancer Institute and Brigham and Women’s Hospital.
Building on his work at Harvard Medical School, Dr. Bahary is using insights gained by studying vertebrate development to determine how cancers grow. Clinical trials emanating from this research will continue at AHN Cancer Institute, and are expected to lead to the development of new targeted agents and immunologic strategies for treating cancer. At AHN Cancer Institute, he will serve in the roles of Academic Chief of Medical Oncology and Director of the AHNCI clinical research program.
MD, Ph.D
Wes Bunch
As the co-founder of Bridgehead IT Inc., Wes Bunch has over 22 years of experience in IT Service delivery. His background includes business analysis, process assessment, change management, operational improvement, Infrastructure Support, and project management. Wes also has a soft spot for Cisco Internetworking and RF engineering. Wes focuses on leading Bridgehead IT’s large-scale ITSM implementations, R&D, strategic and technical alliances, and sales and marketing outreach.
CEO
MEET THE TEAM
MEET THE TEAM
Meet the Leadership Team
Meet the Leadership Team
Chris Brandvik is one of Bridgehead IT’s founding partners. He brings more than 21 years of technical and management experience. Chris is also our Project Manager and takes great pride in delivering IT Solutions to our new and existing customers. His reputation of seamlessly integrating large scale projects and bringing those projects in on-time and on-budget has helped solidify Bridgehead IT as a premier IT Service Provider in the IT space.
COO
Chris Brandvik
Dr. Beriwal focuses on high-dose brachytherapy for cervix, uterine, vaginal, and breast cancers. He also researches prostate seed implantation, image-guided radiation, and intensity-modulated radiation therapy. He is a fellow of the American Brachytherapy Society and been an integral part of formulating the organization’s guidelines for management of cervix, endometrium, and vaginal cancer. His current clinical research includes 3D image-based brachytherapy and outcome analysis for breast, prostate, and gynecological cancers.
MD, MBA
MEET THE TEAM
MEET THE TEAM
Meet the Leadership Team
Gary Beadle is a Texas native, living in San Antonio since 1992. He has over 20 years of industry experience, including 13 years of software development and IT management, and 10 years in business development. Gary loves getting to know his clients. He’s passionate about understanding clients’ businesses and creating customized solutions to solve business challenges. Gary is married with four children and enjoys spending time outdoors, training for marathons, and playing basketball and golf. Let Gary know about your IT challenges and he will work hard to solve them!
Director of business development
Gary Beadle
Prior to joining AHN Cancer Institute, Dr. Dietz served as Director of Breast Center Operations at University Hospitals Case Medical Center and Associate Professor of Surgery at Case Western Reserve University School of Medicine. Dr. Dietz previously led breast centers at Washington University, Barnes Jewish Hospital, the Cleveland Clinic and University Hospitals of Cleveland. She also served as Chief Quality and Allocation Officer for the Cleveland Clinic ambulatory surgery centers, and as principal at TrueNorth Medical Consulting, she serves as a consultant for breast centers around the world.
Dr. Dietz just completed a two-year term as President of the American Society of Breast Surgeons, during which she led the development of a robust virtual education platform for the organization’s 3,200 members. In that capacity, she also formed the COVID-19 Pandemic Breast Cancer Consortium, gathering leaders from major national cancer organizations to expeditiously publish “Guidelines for the Prioritization and Treatment of Breast Cancer during the Pandemic.” Leveraging her national and international reputation and influence in the field of breast surgical oncology, Dr. Dietz also co-developed “Global Breast Hub,” the first global platform for gathering and sharing data and best practices to decrease gaps in breast cancer care.
MD, FACS
MEET THE TEAM
Meet the Leadership Team